Literature DB >> 14525721

Use of hormone replacement therapy among Danish nurses at increased risk of osteoporosis.

Yrsa Andersen Hundrup1, Henrik Thoning, Niels Kristian Rasmussen, Erik Bernhard Obel, John Philip.   

Abstract

Observational studies and recent randomized trials have shown that postmenopausal hormone replacement therapy (HRT) may reduce the risk of osteoporotic fractures by about 30 to 40%. In this study we used a log linear graphical model to determine whether women with a known increased risk of osteoporosis were more likely to use HRT than other women and to examine whether women at increased risk modified this risk through their lifestyle. Cox regression analysis was used to analyze if women at risk of osteoporosis used HRT longer than women not at risk. Participants were Danish female nurses who, in 1993, were between 50 and 69 years of age (N=14,865). Data were collected from postal questionnaires. We concluded that nurses with a known family history of osteoporosis more often used HRT than nurses without this risk. No other direct associations were found between biological risk factors and ever use of HRT. The presence of biological risk factors of osteoporosis was not consistently modified by a healthier lifestyle. Nurses with a low body mass index (BMI) with a known family history of osteoporosis continued to use HRT longer than nurses without these risk factors.

Entities:  

Mesh:

Year:  2003        PMID: 14525721     DOI: 10.1207/s15327558ijbm1003_06

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  32 in total

1.  Socioeconomic differentials in misclassification of height, weight and body mass index based on questionnaire data.

Authors:  G Boström; F Diderichsen
Journal:  Int J Epidemiol       Date:  1997-08       Impact factor: 7.196

2.  Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause.

Authors:  L Nilas; C Christiansen
Journal:  Eur J Clin Invest       Date:  1988-10       Impact factor: 4.686

3.  Graphical models for panel studies, illustrated on data from the Framingham Heart Study.

Authors:  J P Klein; N Keiding; S Kreiner
Journal:  Stat Med       Date:  1995-06-30       Impact factor: 2.373

4.  Multiparity and bone mass.

Authors:  H Bererhi; N Kolhoff; A Constable; S P Nielsen
Journal:  Br J Obstet Gynaecol       Date:  1996-08

5.  [Hormone replacement therapy reduces the risk of forearm fracture in postmenopausal women. Results of the Danish Osteoporosis Prevention Study].

Authors:  L Mosekilde; H Beck-Nielsen; O H Sørensen; S P Nielsen; P Charles; P Vestergaard; A P Hermann; J Gram; T B Hansen; B Abrahamsen; E N Ebbesen; L S Stilgren; L B Jensen; C Brot; B Hansen; C L Tofteng; P A Eiken; N U Kolthoff
Journal:  Ugeskr Laeger       Date:  2001-12-10

6.  Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

Authors:  K M Brett; J H Madans
Journal:  Am J Epidemiol       Date:  1997-03-15       Impact factor: 4.897

7.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

Authors:  D P Kiel; D T Felson; J J Anderson; P W Wilson; M A Moskowitz
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

8.  Relation between body size and bone mineral density in elderly men and women.

Authors:  S L Edelstein; E Barrett-Connor
Journal:  Am J Epidemiol       Date:  1993-08-01       Impact factor: 4.897

9.  Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study.

Authors:  O Johnell; B Gullberg; J A Kanis; E Allander; L Elffors; J Dequeker; G Dilsen; C Gennari; A Lopes Vaz; G Lyritis
Journal:  J Bone Miner Res       Date:  1995-11       Impact factor: 6.741

10.  Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.

Authors:  J A Cauley; D G Seeley; K Ensrud; B Ettinger; D Black; S R Cummings
Journal:  Ann Intern Med       Date:  1995-01-01       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.